| Ytd | -12.06% | |
| 1y | -13.84% |
| Open | 20.31 | Prev Close | 20.19 | Low | 20.26 | High | 20.93 | Mkt Cap | 2.66B |
| Vol | 1.13M | Avg Vol | 1.24M | EPS | 0.21 | P/E | 99.29 | Forward P/E | 19.61 |
| Beta | 0.80 | Short Ratio | 4.63 | Inst. Own | 98.53% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 20.99 | 200-d Avg | 22.80 | 1yr Est | 31.47 |
ARLINGTON, Va., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today ann
RICHMOND, Va.--(BUSINESS WIRE)--Anthem Blue Cross and Blue Shield in Virginia and Privia Health have
Privia Health Gr (NASDAQ:PRVA) released second-quarter financial results and hosted an earnings call
Privia Health Group (NASDAQ: PRVA - Get Free Report) and Guardant Health (NASDAQ: GH - Get Free Repo
Bank of New York Mellon Corp acquired a new stake in Privia Health Group, Inc. (NASDAQ: PRVA) in the
Deutsche Bank AG purchased a new stake in shares of Privia Health Group, Inc. (NASDAQ: PRVA) in the
BlackRock Inc. acquired a new stake in shares of Privia Health Group, Inc. (NASDAQ: PRVA) in the sec
ARLINGTON, Va., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced
Privia Health Group NASDAQ: PRVA reported second-quarter results marked by double-digit growth in im
On August 06, 2026, Privia Health Group Inc (PRVA) shares fell 8.2% today, bringing the current pric
Privia Health Group, Inc. (PRVA) Q2 2026 Earnings Call Transcript
Although the revenue and EPS for Privia Health (PRVA) give a sense of how its business performed in
Privia Health Gr (NASDAQ:PRVA) reported quarterly earnings of $0.19 per share which beat the analyst
Privia Health (PRVA) came out with quarterly earnings of $0.07 per share, missing the Zacks Consensu
Privia Health Gr (NASDAQ:PRVA) affirms FY2026 sales outlook from $2.350 billion-$2.450 billion to $2
2Q'26 Net Income of $9.0M, +236.7% from 2Q'25 2Q'26 Adjusted EBITDA of $37.4M, +29.1% from 2Q'25 Ful
Dimensional Fund Advisors LP grew its stake in Privia Health Group, Inc. (NASDAQ: PRVA) by 6.3% duri
On July 22, 2026, Privia Health Group Inc (PRVA) shares fell 3.6% today, bringing the current price
Warning: RSI is above 70 for 3 overbought stocks in healthcare. Progyny, 10X Genomics, and Privia He
Former CEO Shawn Morris sold 135,498 shares on June 30 and July 1, 2026, generating proceeds of ~$3.
ARLINGTON, Va., July 07, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today ann
CEO Parth Mehrotra sold 121,086 shares directly for a total of ~$2.73 million at an average price of
On June 04, 2026, Privia Health Group Inc (PRVA) shares rose 3.4% to a current price of $21.37. Over
Privia Health Group delivers technology-driven solutions to optimize physician practices and support
Canaccord Genuity analyst Richard Close maintains Privia Health Gr (NASDAQ:PRVA) with a Buy and l
Privia Health Gr (NASDAQ:PRVA) affirms FY2026 sales outlook from $2.350 billion-$2.450 billion to $2
Privia Health Gr (NASDAQ:PRVA) reported quarterly earnings of $0.19 per share which beat the analyst
Evercore ISI Group analyst Elizabeth Anderson maintains Privia Health Gr (NASDAQ:PRVA) with a Out
Barclays analyst Andrew Mok maintains Privia Health Gr (NASDAQ:PRVA) with a Equal-Weight and rais
Citigroup analyst Daniel Grosslight maintains Privia Health Gr (NASDAQ:PRVA) with a Buy and lower
Amalgam Rx, Inc., a leader in data-driven, AI-powered healthcare engagement and clinical decision su
Truist Securities analyst Jailendra Singh maintains Privia Health Gr (NASDAQ:PRVA) with a Buy and
Canaccord Genuity analyst Richard Close maintains Privia Health Gr (NASDAQ:PRVA) with a Buy and r
Privia Health Gr (NASDAQ:PRVA) sees FY2026 sales of $2.350 billion-$2.450 billion vs $2.380 billion
Privia Health Gr (NASDAQ:PRVA) reported quarterly earnings of $0.25 per share which beat the analyst
Renaissance Group made massive moves in Netflix, Lam Research and ServiceNow, signaling rising hedge
CMS raises 2026 Medicare Advantage payments by 5.06%, exceeding projections and benefiting insurers
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly los
Shares of Panbela Therapeutics, Inc. (NASDAQ: PBLA) fell sharply during Monday’s session after the c
U.S. stocks traded higher, with the Dow Jones gaining around 200 points on Friday. Here are some big
Companies Reporting Before The Bell • Arcutis Biotherapeutics (NASDAQ:ARQT) is expected to report q
Gainers MSP Recovery, Inc. (NASDAQ: LIFW) shares jumped 127.8% to $0.1269. The company recently